Moderna $900M Debt Financing with Ares Capital Corporation
Moderna entered into an amendment to its existing Credit and Guaranty Agreement with Ares Capital Corporation, reducing interest rate margins by 0.75 percentage points and extending the maturity date to November 24, 2031. The amendment also extends the availability period for $900 million in delayed draw term loan commitments through November 2029.
- Value
- $900M
- Counterparty
- Ares Capital Corporation
- Term
- through Nov 2031